表紙:細胞治療薬・遺伝子治療薬製造の世界市場:タイプ別(細胞治療薬製造、遺伝子治療薬製造)、規模別、モード別、ワークフロー別、地域別の、市場規模調査と予測(2021年~2027年)
市場調査レポート
商品コード
1019222

細胞治療薬・遺伝子治療薬製造の世界市場:タイプ別(細胞治療薬製造、遺伝子治療薬製造)、規模別、モード別、ワークフロー別、地域別の、市場規模調査と予測(2021年~2027年)

Global Cell and Gene Therapy Manufacturing Market Size study, by Type (Cell Therapy Manufacturing Gene Therapy Manufacturing) by Scale, by Mode, by workflow and Regional Forecasts 2021-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
細胞治療薬・遺伝子治療薬製造の世界市場:タイプ別(細胞治療薬製造、遺伝子治療薬製造)、規模別、モード別、ワークフロー別、地域別の、市場規模調査と予測(2021年~2027年)
出版日: 2021年07月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞治療薬・遺伝子治療薬製造の市場規模は2020年に約131億米ドルとなり、2021年~2027年の予測期間中に20.3%を超える健全な成長率で成長すると予想されています。

細胞治療中、細胞は患者に注入される前に体外で発達または変化し、そこで生薬に成長します。遺伝子治療中、遺伝子は、病気を治療するために、体の外側または内側のいずれかの細胞に置換、非活性化、または創始されます。細胞および遺伝子治療は、単に症状を処理するのではなく、病気を終わらせるか、その進行を覆すと考えられています。それらは多くの場合、病気の根本的な原因を減らし、特定の状態を治す能力を持っているかもしれない一回限りの治療です。

細胞および遺伝子治療のパイプラインの成長は、細胞治療薬・遺伝子治療薬製造市場を活性化することも期待されています。たとえば、かなりの数の企業が委託製造業者と協力して候補薬を製造しています。CMO/CDMOは、サービスに対する需要の高まりに対応するために、製造能力を開発し続けています。2020年5月、Thermo Fisher Scientificは、ウイルスベクターの生産能力を2倍に拡大するために、1億8,000万米ドルのかなりの金額を投資しました。また、支援規制機関はまた、細胞治療薬・遺伝子治療薬製造市場の成長のための市場成長を推進しています。

当レポートでは細胞治療薬・遺伝子治療薬製造の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、タイプ・規模・モード・ワークフロー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の定義と範囲

第3章 市場力学

  • 市場の影響分析(2019年~2027年)

第4章 業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 タイプ別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 細胞治療薬製造
    • 遺伝子治療薬製造

第6章 規模別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • プレコマーシャル/R&Dスケール製造
    • 商業規模の製造

第7章 モード別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 受託製造
    • 内製

第8章 ワークフロー別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 細胞処理
    • セルバンキング
    • プロセス開発
    • 充填および仕上げ操作
    • 分析および品質テスト
    • 原材料のテスト
    • ベクター制作
    • その他

第9章 地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza
    • Catalent Inc.
    • Takara Bio Inc.
    • F. Hoffmann-La Roche Ltd
    • Wuxi Advanced Therapies
    • Samsung Biologics
    • Boehringer Ingelheim
    • Novartis AG

第11章 調査アプリケーション

  • 調査アプリケーション
    • データマイニング
    • 分析
    • 市場の見積もり
    • 検証
    • 出版
  • 調査属性
  • 調査の前提
図表

LIST OF TABLES

  • TABLE 1. Global Cell and Gene Therapy Manufacturing Market , report scope
  • TABLE 2. Global Cell and Gene Therapy Manufacturing Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Cell and Gene Therapy Manufacturing Market estimates & forecasts by Type 2018-2027 (USD Billion)
  • TABLE 4. Global Cell and Gene Therapy Manufacturing Market estimates & forecasts by Scale 2010-2027 (USD Billion)
  • TABLE 5.
  • TABLE 6. Global Cell and Gene Therapy Manufacturing Market estimates & forecasts by Mode 2018-2027 (USD Billion)
  • TABLE 7. Global Cell and Gene Therapy Manufacturing Market Estimate & forecasts by Workflow 2018-2027 (USD Billion)
  • TABLE 8. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. Global Cell and Gene Therapy Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. Global Cell and Gene Therapy Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. U.S. Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. U.S. Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. U.S. Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. Canada Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. Canada Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. Canada Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. UK Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. UK Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. UK Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. Germany Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. Germany Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. Germany Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. France Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. France Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. France Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Spain Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Spain Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Spain Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. Italy Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. Italy Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Italy Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. ROE Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. ROE Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. ROE Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. China Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. China Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. China Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. India Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. India Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. India Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Japan Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Japan Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Japan Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. Australia Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 58. Australia Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. Australia Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. South Korea Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 61. South Korea Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. South Korea Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. ROPAC Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 64. ROPAC Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. ROPAC Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Brazil Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 67. Brazil Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Brazil Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. Mexico Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 70. Mexico Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. Mexico Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROLA Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 73. ROLA Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROLA Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. ROW Cell and Gene Therapy Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 76. ROW Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 77. ROW Cell and Gene Therapy Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 78. List of secondary sources used in the study of global Cell and Gene Therapy Manufacturing Market .
  • TABLE 79. List of primary sources used in the study of global Cell and Gene Therapy Manufacturing Market .
  • TABLE 80. Years considered for the study.
  • TABLE 81. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Cell and Gene Therapy Manufacturing Market , research methodology
  • FIG 2. Global Cell and Gene Therapy Manufacturing Market , market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cell and Gene Therapy Manufacturing Market , key trends 2019
  • FIG 5. Global Cell and Gene Therapy Manufacturing Market , growth prospects 2020-2027
  • FIG 6. Global Cell and Gene Therapy Manufacturing Market , porters 5 force model
  • FIG 7. Global Cell and Gene Therapy Manufacturing Market , pest analysis
  • FIG 8. Global Cell and Gene Therapy Manufacturing Market , value chain analysis
  • FIG 9. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Cell and Gene Therapy Manufacturing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Cell and Gene Therapy Manufacturing Market , regional snapshot 2018 & 2027
  • FIG 18. North America Cell and Gene Therapy Manufacturing Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Cell and Gene Therapy Manufacturing Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Cell and Gene Therapy Manufacturing Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Cell and Gene Therapy Manufacturing Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Cell and Gene Therapy Manufacturing Market , company market share analysis (2019)
目次

Global Cell and Gene Therapy Manufacturing Market is valued at approximately USD 13.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 20.3% over the forecast period 2021-2027. During cell therapy, cells are developed or altered outside the body before being injected into the patient, where they grow into a living drug. During gene therapy, genes are substituted, deactivated or initiated into cells-either outside or inside the body-to treat a disease. Cell and gene therapies are conceived to terminate a disease or overturn its progress instead of simply handling the symptoms. They are often one-time treatments that may lessen the underlying cause of a disease and have the ability to cure certain conditions. Growing pipeline of cell and gene therapy is also expected to fuel the Cell and Gene Therapy Manufacturing Market. For instance, A significant number of companies are cooperating with contract manufacturers to produce their drug candidates. CMOs/CDMOs continue to develop their manufacturing capabilities to meet the rising demand for services. In May 2020, The thermo Fisher Scientific invested a considerable amount of USD 180 Million for the growth of its viral vector production capacity twofold. Also, supportive regulatory bodies are also propelling the market growth for cell and gene manufacturing market growth.

However, technological challenges associated with manufacturing and high cost of manufacturing may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Cell and Gene Therapy Manufacturing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America led the cell and gene therapy manufacturing market and accounted for the greatest revenue share of 43.0% in 2020. A significant number of current clinical trials coupled with the rising commitment of companies in the R&D of gene and cell therapy is the major driving factor for regional market growth. .

In Europe, multiple new cooperative research and innovation projects were launched, under Horizon 2020 initiatives. These projects include viral vector-based gene therapy trials for rare conditions. This is expected to drive the growth of cell and gene therapy manufacturing services across the European nations. A strong facility network coupled with a strong workforce in European countries is anticipated to further fuel the market growth.

Major market player included in this report are:

Thermo Fisher Scientific

Merck KGaA

Lonza

Catalent Inc.

Takara Bio Inc.

F. Hoffmann-La Roche Ltd

Wuxi Advanced Therapies

Samsung Biologics

Boehringer Ingelheim

Novartis AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Cell Therapy Manufacturing(Stem Cell Therapy, Non-Stem Cell Therapy)

Gene Therapy Manufacturing

By Scale :

Pre-commercial/ R&D Scale Manufacturing

Commercial Scale Manufacturing

By Mode:

Contract Manufacturing

In-house Manufacturing

By Workflow:

Cell Processing

Cell Banking,

Process Development,

Fill & Finish Operations,

Analytical and Quality Testing,

Raw Material Testing,

Vector Production,

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year -2018,2019

Base year -2020

Forecast period - 2021 to 2027.

Target Audience of the Global Cell and Gene Therapy Manufacturing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Cell and Gene Therapy Manufacturing Market , by Region, 2019-2027 (USD Billion)
    • 1.2.2. Cell and Gene Therapy Manufacturing Market , by Type, 2019-2027 (USD Billion)
    • 1.2.3. Cell and Gene Therapy Manufacturing Market , by Scale , 2019-2027 (USD Billion)
    • 1.2.4. Cell and Gene Therapy Manufacturing Market , by Mode, 2019-2027 (USD Billion)
    • 1.2.5. Cell and Gene Therapy Manufacturing Market, by Workflow, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cell and Gene Therapy Manufacturing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cell and Gene Therapy Manufacturing Market Dynamics

  • 3.1. Cell and Gene Therapy Manufacturing Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing pipeline of cell and Gene therapy
      • 3.1.1.2. Supportive regulatory bodies
    • 3.1.2. Market Restraint
      • 3.1.2.1. Technological challenges associated with manufacturing
      • 3.1.2.2. High cost of manufacturing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising pressure on drug developers/manufacturers to meet growing market demand

Chapter 4. Global Cell and Gene Therapy Manufacturing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cell and Gene Therapy Manufacturing Market , by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cell and Gene Therapy Manufacturing Market by Type , Performance - Potential Analysis
  • 5.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
  • 5.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
    • 5.4.1. Cell Therapy Manufacturing
      • 5.4.1.1. Stem Cell Therapy
      • 5.4.1.2. Non-Stem Cell Therapy
    • 5.4.2. Gene Therapy Manufacturing

Chapter 6. Global Aniline Derivative Market, By Scale

  • 6.1. Market Snapshot
  • 6.2. Global Cell and Gene Therapy Manufacturing Market by Scale, Performance - Potential Analysis
  • 6.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Scale 2018-2027 (USD Billion)
  • 6.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
    • 6.4.1. Pre-commercial/ R&D Scale Manufacturing
    • 6.4.2. Commercial Scale Manufacturing

Chapter 7. Global Cell and Gene Therapy Manufacturing Market , by Mode

  • 7.1. Market Snapshot
  • 7.2. Global Bot Global Cell and Gene Therapy Manufacturing Market by Mode Performance - Potential Analysis
  • 7.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Mode 2018-2027 (USD Billion)
  • 7.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
    • 7.4.1. Contract Manufacturing
    • 7.4.2. In-house Manufacturing

Chapter 8. Global Cell and Gene Therapy Manufacturing Market, By Workflow

  • 8.1. 8.1 Market Snapshot
  • 8.2. Global Bot Global Cell and Gene Therapy Manufacturing Market by Workflow Performance - Potential Analysis
  • 8.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Workflow 2018-2027 (USD Billion)
  • 8.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
    • 8.4.1. Cell Processing
    • 8.4.2. Cell Banking
    • 8.4.3. Process Development
    • 8.4.4. Fill & Finish Operations
    • 8.4.5. Analytical And Quality Testing
    • 8.4.6. Raw Material Testing
    • 8.4.7. Vector Production
    • 8.4.8. Others

Chapter 9. Global Cell and Gene Therapy Manufacturing Market , Regional Analysis

  • 9.1. Cell and Gene Therapy Manufacturing Market , Regional Market Snapshot
  • 9.2. North America Cell and Gene Therapy Manufacturing Market
    • 9.2.1. U.S. Cell and Gene Therapy Manufacturing Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. End use breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Cell and Gene Therapy Manufacturing Market
  • 9.3. Europe Cell and Gene Therapy Manufacturing Market Snapshot
    • 9.3.1. U.K. Cell and Gene Therapy Manufacturing Market
    • 9.3.2. Germany Cell and Gene Therapy Manufacturing Market
    • 9.3.3. France Cell and Gene Therapy Manufacturing Market
    • 9.3.4. Spain Cell and Gene Therapy Manufacturing Market
    • 9.3.5. Italy Cell and Gene Therapy Manufacturing Market
    • 9.3.6. Rest of Europe Cell and Gene Therapy Manufacturing Market
  • 9.4. Asia-Pacific Cell and Gene Therapy Manufacturing Market Snapshot
    • 9.4.1. China Cell and Gene Therapy Manufacturing Market
    • 9.4.2. India Cell and Gene Therapy Manufacturing Market
    • 9.4.3. Japan Cell and Gene Therapy Manufacturing Market
    • 9.4.4. Australia Cell and Gene Therapy Manufacturing Market
    • 9.4.5. South Korea Cell and Gene Therapy Manufacturing Market
    • 9.4.6. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market
  • 9.5. Latin America Cell and Gene Therapy Manufacturing Market Snapshot
    • 9.5.1. Brazil Cell and Gene Therapy Manufacturing Market
    • 9.5.2. Mexico Cell and Gene Therapy Manufacturing Market
  • 9.6. Rest of The World Cell and Gene Therapy Manufacturing Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Merck KGaA
    • 10.2.3. Lonza
    • 10.2.4. Catalent Inc.
    • 10.2.5. Takara Bio Inc.
    • 10.2.6. F. Hoffmann-La Roche Ltd
    • 10.2.7. Wuxi Advanced Therapies
    • 10.2.8. Samsung Biologics
    • 10.2.9. Boehringer Ingelheim
    • 10.2.10. Novartis AG

Chapter 11. Research Application

  • 11.1. Research Application
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption